Drug: infliximab, recombinant Quarter: 2016Q3
Total Drug/Injury Combinations: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| INFLIXIMAB, RECOMBINANT | Atypical fibroxanthoma | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Behcet's syndrome | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Contraindication to vaccination | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Dementia with Lewy bodies | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Diffuse large B-cell lymphoma stage III | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Drug effect decreased | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Dyspnoea | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Epstein-Barr virus infection | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Gastrointestinal disorder | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Hepatic steatosis | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Hot flush | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Hypertension | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Hyperthermia | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Inappropriate schedule of drug administration | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Lymphoma | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Orthostatic hypotension | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Parkinson's disease | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Pneumonia streptococcal | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Psoriatic arthropathy | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Pulmonary tuberculosis | 3 | view events |
Total Drug/Injury Combinations: 276 Number of Pages: 14
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)